Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lisa A. Beck, MD
University of Rochester
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California San Diego
La Jolla, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Stanford University
Stanford, California, United States
- National Jewish Health
Denver, Colorado, United States
- University of Florida
Gainesville, Florida, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Duke University
Durham, North Carolina, United States
- Oregon Health Sciences University
Portland, Oregon, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Jul 2018
- Primary completion
- 3 Apr 2020
- Completion
- 9 Sept 2020
- Last update posted
- 4 Oct 2021
- Registered enrollment
- 72
- Registry id
- NCT03389893
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.